U.S. Markets closed

EARNINGS: Mylan stock drops after EpiPen sales slump

Yahoo Finance's Alexis Christoforous and Jared Blikre break down the latest market action after Mylan reported second quarter earnings that missed Wall Street expectations for net income and revenue.